Skip to main content
. 2020 Feb 5;11:79. doi: 10.3389/fimmu.2020.00079

Figure 1.

Figure 1

Consort diagram for RituxiCAN-C4 trial. *Indicates 47 patients included in the exploratory analysis. According to pre-specified second interim per protocol analysis.